FS Moghrabi, A Aburub, HM Fadda - Pharmaceutical Research, 2022 - Springer
Purpose pH-dependent drug-drug interactions (DDIs) with poorly soluble, weakly basic
drugs may lead to clinical implications. Dasatinib is a tyrosine kinase inhibitor with reduced …